Danny Covey, M.A.
About Danny Covey, M.A.
Danny Covey, M.A., is a Marketing Support Specialist at AWT Labels & Packaging with extensive experience in marketing, graphic design, and education. He has held various teaching positions at Algonquin College and Pensacola Christian College, and authored a guide on clinical trials labeling.
Work at AWT Labels & Packaging
Danny Covey has been employed at AWT Labels & Packaging as a Marketing Support Specialist since 2022. His role involves utilizing his diverse skill set in marketing and graphic design to support the company's branding and promotional efforts. AWT Labels & Packaging is located at 2714 Fenton Road, Ottawa, ON K1T 3T7.
Previous Experience at Algonquin College
Danny Covey served as an instructor at Algonquin College for several years. He taught Life Drawing from 2010 to 2016 and Interpretive Illustration from 2015 to 2016. Additionally, he worked as a Field Sketching Instructor from 2017 to 2021. All these positions were held at the college's campus located at 1385 Woodroffe Ave, Ottawa, ON K2G 1V8.
Educational Background
Danny Covey holds a Master of Arts (MA) degree in Commercial Art from Pensacola Christian College, which he completed from 1999 to 2001. He also earned a Bachelor of Science (BS) in Commercial Art and Advertising from the same institution, studying from 1995 to 1999. His foundational education includes a High School Diploma from Sir Wilfrid Laurier Secondary School, achieved between 1990 and 1994.
Diverse Skill Set and Expertise
Danny Covey possesses a diverse skill set that encompasses marketing, graphic design, illustration, video production, and videography. His experience allows him to effectively create engaging content and visual narratives that resonate with clients. He is dedicated to understanding client needs and ensuring their objectives are met through creative solutions.
Published Work and Contributions
Danny Covey authored a guide titled 'The Rise of Biologics and Implications on Clinical Trials Labeling,' which was published on March 12, 2024. This work reflects his expertise in the field and contributes to the ongoing dialogue surrounding clinical trials and labeling practices.